Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

A D Snow, H Mar, D Nochlin, R T Sekiguchi, K Kimata, Y Koike, T N Wight
Author Information
  1. A D Snow: Department of Pathology, University of Washington, Seattle 98195.

Abstract

A monoclonal antibody (HK-249) that recognizes a glucosamine sulfate alpha 1----4 glucuronic acid-containing determinant in heparan sulfate (HS) chains of a basement membrane-derived heparan sulfate proteoglycan identified and immunolocalized HS specifically to the amyloid deposits in neuritic plaques (NPs), congophilic angiopathy (CA), as well as in neurofibrillary tangles (NFTs) and non-tangle-bearing neurons in the brains of Alzheimer's and Down's syndrome (DS) patients. Ultrastructural immunohistochemistry demonstrated that HS within neurons of Alzheimer's disease (AD) brain was localized to lipofuscin granules, an aging pigment previously shown also to contain beta-amyloid protein (BAP). Heparan sulfate also was localized to neurite-containing, nonfibrillar 'primitive' plaques that also demonstrated positive BAP immunoreactivity in both AD and DS brains. Antibodies to laminin, fibronectin, and a chondroitin sulfate proteoglycan failed to show positive immunostaining of the HS-containing sites described above. Analysis of DS patients at different ages revealed that HS accumulated within neurons of the hippocampus and amygdala as early as 1 day after birth. Young age-matched controls did not demonstrate similar positive HS immunoreactivity in neurons, whereas positive immunostaining for HS was observed in other regions thought to normally contain HS. The earliest deposition of BAP was first observed as 'amorphous' or 'diffuse' cortical deposits in DS brain in patients aged 18 and 24 years before the accumulation of fibrillar amyloid (observed in DS patients who are 35 years and older). These cortical deposits also contained positive HS immunoreactivity, implying that HS accumulation in conjunction with the BAP is an early event that ultimately may contribute to the early age-related accumulation (ie, as early as 35 years of age in DS) of NPs, NFTs, and/or CA. Furthermore the colocalization of HS and BAP in a number of specific locales in AD and DS brain indicates a possible interaction between these two macromolecules that may be important in lesion development in these two diseases.

References

  1. Appl Pathol. 1984;2(6):357-69 [PMID: 6242724]
  2. Biochem J. 1988 Dec 15;256(3):775-83 [PMID: 3223951]
  3. J Immunol. 1979 Jun;122(6):2430-4 [PMID: 312868]
  4. J Comp Neurol. 1979 Jul 1;186(1):109-16 [PMID: 156741]
  5. Cell. 1980 Aug;21(1):37-45 [PMID: 6157479]
  6. Br J Psychiatry. 1982 Feb;140:142-8 [PMID: 7074296]
  7. Exp Gerontol. 1982;17(6):481-7 [PMID: 6763901]
  8. Mech Ageing Dev. 1984 Apr-May;25(1-2):189-204 [PMID: 6202988]
  9. Acta Neuropathol. 1984;63(1):72-7 [PMID: 6233838]
  10. J Neurol Neurosurg Psychiatry. 1986 Nov;49(11):1213-20 [PMID: 2432188]
  11. J Histochem Cytochem. 1987 Apr;35(4):419-25 [PMID: 3546488]
  12. Science. 1987 Mar 27;235(4796):1641-4 [PMID: 3029875]
  13. Neurobiol Aging. 1986 Nov-Dec;7(6):425-32 [PMID: 3104810]
  14. Hum Pathol. 1987 May;18(5):506-10 [PMID: 3570282]
  15. Proc Natl Acad Sci U S A. 1987 May;84(9):3033-6 [PMID: 3033674]
  16. Lab Invest. 1987 Aug;57(2):230-6 [PMID: 2441141]
  17. Biochem J. 1987 Jul 15;245(2):543-50 [PMID: 2959275]
  18. Chem Phys Lipids. 1987 Jul-Sep;44(2-4):297-325 [PMID: 3311421]
  19. Biochemistry. 1987 Oct 6;26(20):6407-10 [PMID: 3427015]
  20. Neurobiol Aging. 1987 Nov-Dec;8(6):521-45 [PMID: 3323927]
  21. Cell. 1988 Feb 26;52(4):487-501 [PMID: 3257719]
  22. Mech Ageing Dev. 1988 Jan;42(1):63-73 [PMID: 3347098]
  23. J Cell Biol. 1988 Jun;106(6):2203-10 [PMID: 2454934]
  24. J Neurol Sci. 1988 May;85(1):9-15 [PMID: 2968440]
  25. Science. 1988 Jul 8;241(4862):223-6 [PMID: 2968652]
  26. Mech Ageing Dev. 1988 May;43(2):99-136 [PMID: 2969441]
  27. J Cell Biol. 1988 Aug;107(2):743-51 [PMID: 2971068]
  28. J Histochem Cytochem. 1988 Oct;36(10):1211-21 [PMID: 3047228]
  29. J Biol Chem. 1985 Jun 10;260(11):7029-34 [PMID: 3997857]
  30. Histopathology. 1988 Aug;13(2):125-37 [PMID: 2971602]
  31. J Histochem Cytochem. 1988 Nov;36(11):1387-95 [PMID: 2844888]
  32. Biochem Biophys Res Commun. 1988 Oct 14;156(1):432-7 [PMID: 3140814]
  33. Am J Pathol. 1988 Dec;133(3):456-63 [PMID: 2974240]
  34. Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 [PMID: 6375662]
  35. Neurology. 1967 Apr;17(4):381-94 [PMID: 6067072]
  36. J Neuropathol Exp Neurol. 1968 Apr;27(2):167-82 [PMID: 5646193]
  37. Am J Med. 1969 Nov;47(5):673-90 [PMID: 4242811]
  38. Am J Med. 1969 Nov;47(5):691-707 [PMID: 4243120]
  39. Acta Neuropathol. 1988;77(2):113-9 [PMID: 2465658]
  40. Biochem J. 1989 Jan 1;257(1):191-6 [PMID: 2920011]
  41. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2853-7 [PMID: 2649895]
  42. Am J Pathol. 1989 May;134(5):973-8 [PMID: 2524164]
  43. Neurobiol Aging. 1989 Mar-Apr;10(2):125-32 [PMID: 2657463]
  44. Acta Neuropathol. 1989;78(2):113-23 [PMID: 2473592]
  45. Arch Neurol. 1989 Aug;46(8):849-53 [PMID: 2527024]
  46. Ann Med. 1989;21(2):133-6 [PMID: 2669845]
  47. Nature. 1989 Sep 14;341(6238):144-7 [PMID: 2506449]
  48. Neuropathol Appl Neurobiol. 1989 Jul-Aug;15(4):317-29 [PMID: 2528701]
  49. Acta Neuropathol. 1989;78(4):337-47 [PMID: 2551122]
  50. J Neuropathol Exp Neurol. 1989 Nov;48(6):674-91 [PMID: 2677252]
  51. Nature. 1989 Oct 12;341(6242):546-9 [PMID: 2507928]
  52. Neurobiol Aging. 1989 Sep-Oct;10(5):481-97 [PMID: 2682326]
  53. Ann Neurol. 1989 Nov;26(5):628-34 [PMID: 2554792]
  54. Brain. 1974 Sep;97(3):481-8 [PMID: 4423477]
  55. Lipids. 1975 Jul;10(7):383-90 [PMID: 1143025]
  56. Biochem J. 1975 Oct;152(1):57-64 [PMID: 2162]
  57. Biochem J. 1976 Nov 15;160(2):129-36 [PMID: 12748]
  58. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3916-20 [PMID: 3889918]
  59. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9 [PMID: 3159021]
  60. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4274-6 [PMID: 3159022]
  61. EMBO J. 1985 Nov;4(11):2757-63 [PMID: 4065091]
  62. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8729-32 [PMID: 2934737]
  63. Proc Natl Acad Sci U S A. 1986 Jun;83(11):4040-3 [PMID: 2424015]
  64. Proc Natl Acad Sci U S A. 1986 Jun;83(11):4044-8 [PMID: 2424016]
  65. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7 [PMID: 3088567]

Grants

  1. P50 AG05136/NIA NIH HHS

MeSH Term

Adolescent
Adult
Aged
Aged, 80 and over
Alzheimer Disease
Amygdala
Amyloid beta-Peptides
Autopsy
Biomarkers
Brain
Cerebellum
Child
Child, Preschool
Down Syndrome
Female
Heparitin Sulfate
Hippocampus
Humans
Immunohistochemistry
Infant
Infant, Newborn
Male
Microscopy, Immunoelectron
Middle Aged
Neurons

Chemicals

Amyloid beta-Peptides
Biomarkers
Heparitin Sulfate

Word Cloud

Created with Highcharts 10.0.0HSDSsulfateneuronsBAPpositivepatientsalsoearlyaccumulationheparandepositsAlzheimer'sADbrainimmunoreactivityobservedyearsproteoglycanamyloidplaquesNPsCANFTsbrainsDown'ssyndromedemonstratedwithindiseaselocalizedcontainbeta-amyloidimmunostainingcortical35maytwomonoclonalantibodyHK-249recognizesglucosaminealpha1----4glucuronicacid-containingdeterminantchainsbasementmembrane-derivedidentifiedimmunolocalizedspecificallyneuriticcongophilicangiopathywellneurofibrillarytanglesnon-tangle-bearingUltrastructuralimmunohistochemistrylipofuscingranulesagingpigmentpreviouslyshownproteinHeparanneurite-containingnonfibrillar'primitive'AntibodieslamininfibronectinchondroitinfailedshowHS-containingsitesdescribedAnalysisdifferentagesrevealedaccumulatedhippocampusamygdala1daybirthYoungage-matchedcontrolsdemonstratesimilarwhereasregionsthoughtnormallyearliestdepositionfirst'amorphous''diffuse'aged1824fibrillaroldercontainedimplyingconjunctioneventultimatelycontributeage-relatedieageand/orFurthermorecolocalizationnumberspecificlocalesindicatespossibleinteractionmacromoleculesimportantlesiondevelopmentdiseasesEarlyprotein-containinglesions

Similar Articles

Cited By